BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tecza K, Pamula-Pilat J, Lanuszewska J, Butkiewicz D, Grzybowska E. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018;9:9114-36. [PMID: 29507678 DOI: 10.18632/oncotarget.24148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu ZX, Yang Y, Wang G, Wang JQ, Teng QX, Sun L, Lei ZN, Lin L, Chen ZS, Zou C. Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells. Cancer Sci 2020;111:2872-82. [PMID: 32478948 DOI: 10.1111/cas.14505] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
2 Virgili Manrique AC, Salazar J, Arranz MJ, Bagué S, Orellana R, López-pousa A, Cerdà P, Gracia I, Majercakova K, Peiró A, Trullols L, Fernández M, Valverde S, Quintana MJ, Bell O, Artigas-baleri A, Sebio A. Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. JPM 2022;12:618. [DOI: 10.3390/jpm12040618] [Reference Citation Analysis]
3 Winitchaikul T, Sawong S, Surangkul D, Srikummool M, Somran J, Pekthong D, Kamonlakorn K, Nangngam P, Parhira S, Srisawang P. Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells. PLoS One 2021;16:e0254392. [PMID: 34343190 DOI: 10.1371/journal.pone.0254392] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Santos SM, Hartman JL 4th. A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin. Cancer Metab 2019;7:9. [PMID: 31660150 DOI: 10.1186/s40170-019-0201-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jeong J, Kim YJ, Lee DY, Sohn KY, Yoon SY, Kim JW. Mitigating Effect of 1-Palmitoyl-2-Linoleoyl-3-Acetyl-Rac-Glycerol (PLAG) on a Murine Model of 5-Fluorouracil-Induced Hematological Toxicity. Cancers (Basel) 2019;11:E1811. [PMID: 31752148 DOI: 10.3390/cancers11111811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Juan-Carlos PM, Perla-Lidia PP, Stephanie-Talia MM, Mónica-Griselda AM, Luz-María TE. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine. Mol Biol Rep 2021;48:1883-901. [PMID: 33616835 DOI: 10.1007/s11033-021-06155-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen D, Chen G, Ding Y, Wan P, Peng Y, Chen C, Ye H, Zeng X, Ran L. Polysaccharides from the flowers of tea (Camellia sinensis L.) modulate gut health and ameliorate cyclophosphamide-induced immunosuppression. Journal of Functional Foods 2019;61:103470. [DOI: 10.1016/j.jff.2019.103470] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 9.7] [Reference Citation Analysis]
8 Lavdaniti M, Owens DA, Liamopoulou P, Marmara K, Zioga E, Mantzanas MS, Evangelidou E, Vlachou E. Factors Influencing Quality of Life in Breast Cancer Patients Six Months after the Completion of Chemotherapy. Diseases 2019;7:E26. [PMID: 30813488 DOI: 10.3390/diseases7010026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pochini L, Galluccio M, Scalise M, Console L, Indiveri C. OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics. SLAS Discov 2019;24:89-110. [PMID: 30523710 DOI: 10.1177/2472555218812821] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
10 Ioannou C, Ragia G, Balgkouranidou I, Xenidis N, Amarantidis K, Koukaki T, Biziota E, Kakolyris S, Manolopoulos VG. Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine-based chemotherapy toxicity. Pharmacogenomics 2021;22:669-80. [PMID: 34100299 DOI: 10.2217/pgs-2021-0031] [Reference Citation Analysis]
11 Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother 2021;137:111285. [PMID: 33485118 DOI: 10.1016/j.biopha.2021.111285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
12 Kumar DN, Chaudhuri A, Aqil F, Dehari D, Munagala R, Singh S, Gupta RC, Agrawal AK. Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application. Cancers 2022;14:1435. [DOI: 10.3390/cancers14061435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Falck Winther J, Fosså SD, Grabow D, Muraca M, Kaiser M, Kepák T, Kruseova J, Modan-Moses D, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LCM, Brooke RJ, Baedke JL, van Schaik RHN, van den Anker JN, Uitterlinden AG, Bos AME, van Leeuwen FE, van Dulmen-den Broeder E, van der Kooi ALF, van den Heuvel-Eibrink MM, On Behalf Of The PanCareLIFE Consortium. Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers (Basel) 2021;13:4598. [PMID: 34572825 DOI: 10.3390/cancers13184598] [Reference Citation Analysis]
14 Huang S, Yang J, Fu F, Wang C, Guo X, He B, Xiao D, Cai H, Liu M. Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patients. Pharmacogenomics 2021;22:87-98. [PMID: 33356548 DOI: 10.2217/pgs-2020-0080] [Reference Citation Analysis]
15 Gernaat SAM, von Stedingk H, Hassan M, Nilsson HP, Rodriguez-Wallberg KA, Hedayati E, Rydberg P. Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study. Sci Rep 2021;11:2707. [PMID: 33526812 DOI: 10.1038/s41598-021-81662-1] [Reference Citation Analysis]
16 Wang W, Chen J, Luo D, Chen J, Xu H, Chen W, Wang Y. Effects of Low-Intensity Pulsed Ultrasound on Myelosuppression of Rats Induced by Chemotherapy Drugs With Cell Cycle Specificity. J Ultrasound Med 2021;40:1811-22. [PMID: 33174633 DOI: 10.1002/jum.15562] [Reference Citation Analysis]
17 Singh V, Johansson P, Lin YL, Hammarsten O, Westerlund F. Shining light on single-strand lesions caused by the chemotherapy drug bleomycin. DNA Repair (Amst) 2021;105:103153. [PMID: 34119948 DOI: 10.1016/j.dnarep.2021.103153] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Macedo LT, Ferrari VE, Carron J, Costa EFD, Lopes-Aguiar L, Lourenço GJ, Lima CSP. Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach. PLoS One 2019;14:e0213929. [PMID: 30870506 DOI: 10.1371/journal.pone.0213929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
19 Moodley T, Singh M. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy. Molecules 2020;25:E742. [PMID: 32046364 DOI: 10.3390/molecules25030742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Harahap Y, Nurahman F, Purwanto DJ, Yanuar A. The correlation between the level of 3-hydroxypropyl mercapturic acid, CYP2B6 polymorphisms, and hematuria occurrences after cyclophosphamide administration and its bioanalytical methods: A systematic review. Heliyon 2021;7:e08126. [PMID: 34746455 DOI: 10.1016/j.heliyon.2021.e08126] [Reference Citation Analysis]
21 Wu D, Vogus D, Krishnan V, Broto M, Pusuluri A, Zhao Z, Kapate N, Mitragotri S. Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes. Pharmaceutics 2021;13:107. [PMID: 33467652 DOI: 10.3390/pharmaceutics13010107] [Reference Citation Analysis]
22 Samodelov SL, Kullak-Ublick GA, Gai Z, Visentin M. Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology. Int J Mol Sci 2020;21:E7890. [PMID: 33114309 DOI: 10.3390/ijms21217890] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Wang W, Luo D, Chen J, Chen J, Xia Y, Chen W, Wang Y. Amelioration of cyclophosphamide-induced myelosuppression during treatment to rats with breast cancer through low-intensity pulsed ultrasound. Biosci Rep 2020;40:BSR20201350. [PMID: 32936241 DOI: 10.1042/BSR20201350] [Reference Citation Analysis]
24 Santana-Krímskaya SE, Franco-Molina MA, Zárate-Triviño DG, Prado-García H, Zapata-Benavides P, Torres-Del-Muro F, Rodríguez-Padilla C. IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model. Biomed Pharmacother 2020;126:110062. [PMID: 32172064 DOI: 10.1016/j.biopha.2020.110062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Schaller L, Lauschke VM. The genetic landscape of the human solute carrier (SLC) transporter superfamily. Hum Genet 2019;138:1359-77. [PMID: 31679053 DOI: 10.1007/s00439-019-02081-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]